RESULTS	The dexamethasone group had a similar proportion of severely disabled patients among survivors at five years as the placebo group ( 17/128 , 13.2 % vs. 17/116 , 14.7 % ) and there was no significant association between dexamethasone treatment and disability status at five years ( p = 0.32 ) .\